175 related articles for article (PubMed ID: 3320227)
1. Comparative studies on expression of CA 19-9 and DU-PAN-2 in pancreatic cancer tissue.
Takasaki H; Uchida E; Tempero MA; Burnett DA; Metzgar RS; Pour PM
Int J Pancreatol; 1987; 2(5-6):349-60. PubMed ID: 3320227
[TBL] [Abstract][Full Text] [Related]
2. Correlative study on expression of CA 19-9 and DU-PAN-2 in tumor tissue and in serum of pancreatic cancer patients.
Takasaki H; Uchida E; Tempero MA; Burnett DA; Metzgar RS; Pour PM
Cancer Res; 1988 Mar; 48(6):1435-8. PubMed ID: 3162196
[TBL] [Abstract][Full Text] [Related]
3. Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies.
Metzgar RS; Gaillard MT; Levine SJ; Tuck FL; Bossen EH; Borowitz MJ
Cancer Res; 1982 Feb; 42(2):601-8. PubMed ID: 7034925
[TBL] [Abstract][Full Text] [Related]
4. The patterns of coexpression of tumor-associated antigens CA 19-9, TAG-72, and DU-PAN-2 in human pancreatic cancer.
Toshkov I; Mogaki M; Kazakoff K; Pour PM
Int J Pancreatol; 1994 Apr; 15(2):97-103. PubMed ID: 8071575
[TBL] [Abstract][Full Text] [Related]
5. Comparative studies on the expression of tumor-associated glycoprotein (TAG-72), CA 19-9 and DU-PAN-2 in normal, benign and malignant pancreatic tissue.
Takasaki H; Tempero MA; Uchida E; Büchler M; Ness MJ; Burnett DA; Metzgar RS; Colcher D; Schlom J; Pour PM
Int J Cancer; 1988 Nov; 42(5):681-6. PubMed ID: 3053465
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies against human pancreatic adenocarcinoma: distribution of DU-PAN-2 antigen on glandular epithelia and adenocarcinomas.
Borowitz MJ; Tuck FL; Sindelar WF; Fernsten PD; Metzgar RS
J Natl Cancer Inst; 1984 May; 72(5):999-1005. PubMed ID: 6371347
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of CA 19-9, DU-PAN-2, CA 125, and TAG-72 in pancreatic adenocarcinoma.
Tempero M; Takasaki H; Uchida E; Takiyama Y; Colcher D; Metzgar RS; Pour PM
Am J Surg Pathol; 1989; 13 Suppl 1():89-95. PubMed ID: 2699170
[TBL] [Abstract][Full Text] [Related]
8. Blood-group antigen expression during pancreatic cancer induction in hamsters.
Pour PM; Uchida E; Burnett DA; Steplewski Z
Int J Pancreatol; 1986 Dec; 1(5-6):327-40. PubMed ID: 3316427
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical studies on the localization of cancer associated antigens DU-PAN-2 and CA19-9 in carcinomas of the digestive tract.
Ohshio G; Ogawa K; Kudo H; Yamabe H; Nakashima Y; Kim YC; Endo K; Watanabe Y; Manabe T; Tobe T
J Gastroenterol Hepatol; 1990; 5(1):25-31. PubMed ID: 2103381
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of human cancer-associated epitopes on mucin molecules.
Lan MS; Bast RC; Colnaghi MI; Knapp RC; Colcher D; Schlom J; Metzgar RS
Int J Cancer; 1987 Jan; 39(1):68-72. PubMed ID: 2432019
[TBL] [Abstract][Full Text] [Related]
11. Development of intrapancreatic transplantable model of pancreatic duct adenocarcinoma in Syrian golden hamsters.
Egami H; Tomioka T; Tempero M; Kay D; Pour PM
Am J Pathol; 1991 Mar; 138(3):557-61. PubMed ID: 2000935
[TBL] [Abstract][Full Text] [Related]
12. Tissue expression of the tumor marker CA 50 in benign and malignant pancreatic lesions. A comparison with CA 19-9.
Haglund C; Lindgren J; Roberts PJ; Nordling S
Int J Cancer; 1986 Dec; 38(6):841-6. PubMed ID: 3466871
[TBL] [Abstract][Full Text] [Related]
13. Measurement of a pancreatic cancer-associated antigen (DU-PAN-2) detected by a monoclonal antibody in sera of patients with digestive cancers.
Sawabu N; Toya D; Takemori Y; Hattori N; Fukui M
Int J Cancer; 1986 May; 37(5):693-6. PubMed ID: 3457770
[TBL] [Abstract][Full Text] [Related]
14. DU-PAN-2 levels in serum and pancreatic ductal fluids of patients with benign and malignant pancreatic disease.
Mahvi DM; Seigler HF; Meyers WC; Kalthoff H; Schmiegel WH; Metzgar RS
Pancreas; 1988; 3(4):488-93. PubMed ID: 3174610
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis.
Haglund C; Lindgren J; Roberts PJ; Nordling S
Br J Cancer; 1986 Feb; 53(2):189-95. PubMed ID: 3513813
[TBL] [Abstract][Full Text] [Related]
16. [Detection of DU-PAN-2 antigen (pancreatic cancer-associated antigen) in sera of patients with cancer of the digestive tract].
Takami H; Furuuchi T; Ogata Y; Abe O
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3207-14. PubMed ID: 3777958
[TBL] [Abstract][Full Text] [Related]
17. Isolation and properties of a human pancreatic adenocarcinoma-associated antigen, DU-PAN-2.
Lan MS; Finn OJ; Fernsten PD; Metzgar RS
Cancer Res; 1985 Jan; 45(1):305-10. PubMed ID: 3965141
[TBL] [Abstract][Full Text] [Related]
18. Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma.
Metzgar RS; Rodriguez N; Finn OJ; Lan MS; Daasch VN; Fernsten PD; Meyers WC; Sindelar WF; Sandler RS; Seigler HF
Proc Natl Acad Sci U S A; 1984 Aug; 81(16):5242-6. PubMed ID: 6591188
[TBL] [Abstract][Full Text] [Related]
19. Carcinoma of the pancreas. Therapeutic efficacy as defined by a serodiagnostic test utilizing a monoclonal antibody.
Mahvi DM; Meyers WC; Bast RC; Seigler HF; Metzgar RS
Ann Surg; 1985 Oct; 202(4):440-5. PubMed ID: 4051597
[TBL] [Abstract][Full Text] [Related]
20. Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.
Haglund C; Lindgren J; Roberts PJ; Kuusela P; Nordling S
Br J Cancer; 1989 Dec; 60(6):845-51. PubMed ID: 2557879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]